Refine
Has Fulltext
- yes (49)
Is part of the Bibliography
- yes (49)
Year of publication
Document Type
- Journal article (49) (remove)
Language
- English (49)
Keywords
- ischemic stroke (10)
- stroke (8)
- atrial fibrillation (4)
- hypertension (3)
- mortality (3)
- Stroke (2)
- cardiovascular risk factors (2)
- chronic kidney disease (2)
- diabetes mellitus (2)
- epidemiology (2)
- implementation (2)
- incidence (2)
- magnetic resonance imaging (2)
- mental health (2)
- metaanalysis (2)
- myocardial work (2)
- outcomes (2)
- physical activity (2)
- prevalence (2)
- quality of life (2)
- systematic review (2)
- thrombolysis (2)
- troponin (2)
- AKI (1)
- Akutes Nierenversagen (1)
- Atrial fibrillation (1)
- COMT (1)
- COVID-19 (1)
- Calibration (1)
- Cardiac dysfunction| Brain natriuretic peptide (1)
- Cardiovascular risk factors (1)
- Cardiovascular risk prediction (1)
- Carotid intima-media thickness (CIMT) (1)
- Carotid segment (1)
- Carotid ultrasound (1)
- Clinical prediction rule (1)
- Clinically silent stroke (1)
- ECG-recording (1)
- EUROASPIRE survey (1)
- European countries (1)
- False positive reactions (1)
- German Stroke Registers Study Group (1)
- Germany (1)
- Health care service research (1)
- Heart failure (1)
- Herzthoraxchirurgie (1)
- Hesse (1)
- ICD-coding of CKD (1)
- Infection control (1)
- Ischemic stroke (1)
- KDIGO (1)
- LV dilatation (1)
- MASLD (1)
- Metastatic breast cancer (1)
- Methicillin-resistant staphylococcus aureus (1)
- NOAC (1)
- NSSI (1)
- Oral anticoagulation (1)
- Patient-centered care (1)
- Patient-centered registry (1)
- Patient’s needs (1)
- Predictive value of tests (1)
- RCT (1)
- Rehabilitation (1)
- SARS-CoV- 2 (1)
- Secondary stroke prevention (1)
- Social support (1)
- Social work (1)
- Stroke unit (1)
- Survey (1)
- Troponin (1)
- accessibility (1)
- accuracy (1)
- acute ischemic stroke (1)
- acute stroke (1)
- adolescence (1)
- anemia (1)
- anxiety (1)
- areas (1)
- arterial stiffening (1)
- atherosclerosis (1)
- atherothrombosis (1)
- biomarker (1)
- biomarkers (1)
- blood pressure (1)
- blood sampling (1)
- brain edema (1)
- brain endothelium (1)
- breast cancer (1)
- calcification (1)
- cardiac arrhythmia (1)
- cardiac surgery (1)
- cardiovascular events (1)
- care tempis (1)
- carotid artery (1)
- carotid artery disease (1)
- carotid atherosclerosis (1)
- carotid stenosis (1)
- carotid ultrasound (1)
- cerebral microbleeds (1)
- clinical practice (1)
- clinical risk score (1)
- clinical trial (1)
- coagulation (1)
- cohort studies (1)
- comparability (1)
- comprehension (1)
- coronary heart disease (1)
- crantiectomy (1)
- cross-sectional studies (1)
- death (1)
- decompressive surgery (1)
- degree of stenosis (1)
- depression (1)
- diagnosis (1)
- disease (1)
- disease score (1)
- disease severity (1)
- drug therapies (1)
- dysphagia (1)
- echocardiography (1)
- ejection fraction (1)
- emotion regulation (1)
- endoglin (1)
- endovascular treatment (1)
- event rates (1)
- evidence‐based medicine (1)
- exercise (1)
- factor VIII (1)
- factor XI (1)
- factor XII (1)
- family caregiver (1)
- family caregivers (1)
- feasibility (1)
- ferritin (1)
- follow up (1)
- geographic information science (1)
- giant intracranial aneurysm (1)
- guideline adherence (1)
- health care service research (1)
- heart failure (1)
- hemicraniectomy (1)
- hemoglobin (1)
- hemorrhagic stroke (1)
- hospitals (1)
- human behaviour (1)
- hypoxia (1)
- indicators (1)
- infection (1)
- inflammation (1)
- informal care (1)
- informal caregiving (1)
- informed consent (1)
- interview (1)
- intracerebral hemorrhage (1)
- ischaemic stroke (1)
- ischemic-stroke (1)
- kidney function (1)
- left ventricular geometric abnormality (1)
- left ventricular geometry (1)
- left ventricular mass (1)
- left ventricular performance (1)
- left ventricular remodeling (1)
- length of stenosis (1)
- life style (1)
- longitudinal studies (1)
- m-Health (1)
- malignant MCA infarct (1)
- marathon running (1)
- mechanical thrombectomy (1)
- mechanisms (1)
- medical complications (1)
- medical rehabilitation (1)
- mental disorders (1)
- mental illness (1)
- mixed methods (1)
- mortality/survival (1)
- multicenter (1)
- multifactorial (1)
- myocardial infarction (1)
- myocardial work efficiency (1)
- normal values (1)
- outcome (1)
- patients’ awareness (1)
- physical health (1)
- physicians’ awareness (1)
- pilot project (1)
- pneumonia (1)
- point-of-care echocardiography (1)
- population-based studies (1)
- population-based study (1)
- postoperativ (1)
- predictors (1)
- primary prevention (1)
- primary-care physicians (1)
- prognosis (1)
- proteinuria (1)
- quality (1)
- randomized controlled trial (1)
- reference data (1)
- register (1)
- registries (1)
- registry (1)
- regression analysis (1)
- rehabilitation (1)
- reliability (1)
- reperfusion injury (1)
- risk factor (1)
- risk factor control (1)
- salt consumption (1)
- salt-intake-related behavior (1)
- scale (1)
- school-based prevention (1)
- secondary prevention (1)
- self-employed (1)
- self-injury (1)
- shedding (1)
- small business (1)
- smoking-cessation (1)
- steatotic liver disease (1)
- stroke care (1)
- stroke unit (1)
- stroke, acute (1)
- stroke-associated pneumonia (1)
- study-group ADSR (1)
- surgical aneurysm treatment (1)
- survey (1)
- systolic dysfunction (1)
- task force (1)
- telemedicine (1)
- telemedicine network (1)
- territory infaction (1)
- time (1)
- time trends (1)
- transient ischemic attack (1)
- treatment (1)
- trial (1)
- type 2 diabetes (1)
- under-dosing (1)
- universal prevention (1)
- vascular disease (1)
Institute
- Institut für Klinische Epidemiologie und Biometrie (45)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (15)
- Medizinische Klinik und Poliklinik I (14)
- Neurologische Klinik und Poliklinik (10)
- Klinik und Poliklinik für Thorax-, Herz- u. Thorakale Gefäßchirurgie (6)
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (3)
- Frauenklinik und Poliklinik (2)
- Institut für Hygiene und Mikrobiologie (2)
- Institut für Psychotherapie und Medizinische Psychologie (2)
- Institut für diagnostische und interventionelle Neuroradiologie (ehem. Abteilung für Neuroradiologie) (2)
Sonstige beteiligte Institutionen
Functional versus morphological assessment of vascular age in patients with coronary heart disease
(2021)
Communicating cardiovascular risk based on individual vascular age (VA) is a well acknowledged concept in patient education and disease prevention. VA may be derived functionally, e.g. by measurement of pulse wave velocity (PWV), or morphologically, e.g. by assessment of carotid intima-media thickness (cIMT). The purpose of this study was to investigate whether both approaches produce similar results. Within the context of the German subset of the EUROASPIRE IV survey, 501 patients with coronary heart disease underwent (a) oscillometric PWV measurement at the aortic, carotid-femoral and brachial-ankle site (PWVao, PWVcf, PWVba) and derivation of the aortic augmentation index (AIao); (b) bilateral cIMT assessment by high-resolution ultrasound at three sites (common, bulb, internal). Respective VA was calculated using published equations. According to VA derived from PWV, most patients exhibited values below chronological age indicating a counterintuitive healthier-than-anticipated vascular status: for VA(PWVao) in 68% of patients; for VA\(_{AIao}\) in 52% of patients. By contrast, VA derived from cIMT delivered opposite results: e.g. according to VA\(_{total-cIMT}\) accelerated vascular aging in 75% of patients. To strengthen the concept of VA, further efforts are needed to better standardise the current approaches to estimate VA and, thereby, to improve comparability and clinical utility.
Background
Atrial fibrillation (AF) is present in 15–20% of patients with acute ischemic stroke. Oral anticoagulation reduces the risk of AF-related recurrent stroke but clinical guideline recommendations are rather vague regarding its use in the acute phase of stroke. We aimed to assess the current clinical practice of medical stroke prevention in AF patients during the acute phase of ischemic stroke.
Methods
In April 2017, a standardized anonymous questionnaire was sent to clinical leads of all 298 certified stroke units in Germany.
Results
Overall, 154 stroke unit leads participated (response rate 52%). Anticoagulation in the acute phase of stroke is considered feasible in more than 90% of AF patients with ischemic stroke. Clinicians assume that about two thirds of all AF patients (range 20–100%) are discharged on oral anticoagulation. According to local preferences, acetylsalicylic acid is given orally in the majority of patients with delayed initiation of oral anticoagulation. A non-vitamin K-dependent oral anticoagulant (NOAC) is more often prescribed than a vitamin K-dependent oral anticoagulant (VKA). VKA is more often chosen in patients with previous VKA intake than in VKA naive patients. In the minority of patients, stroke unit leads discuss the prescription of a specific oral anticoagulant with the treating general practitioner. Adherence to medical stroke prevention after hospital discharge is not assessed on a regular basis in any patient by the majority of participating stroke centers.
Conclusions
Early secondary stroke prevention in AF patients in German stroke units is based on OAC use but prescription modalities vary in clinical practice.
Occurrence of mental illness and mental health risks among the self-employed: a systematic review
(2021)
We aimed to systematically identify and evaluate all studies of good quality that compared the occurrence of mental disorders in the self-employed versus employees. Adhering to the Cochrane guidelines, we conducted a systematic review and searched three major medical databases (MEDLINE, Web of Science, Embase), complemented by hand search. We included 26 (three longitudinal and 23 cross-sectional) population-based studies of good quality (using a validated quality assessment tool), with data from 3,128,877 participants in total. The longest of these studies, a Swedish national register evaluation with 25 years follow-up, showed a higher incidence of mental illness among the self-employed compared to white-collar workers, but a lower incidence compared to blue-collar workers. In the second longitudinal study from Sweden the self-employed had a lower incidence of mental illness compared to both blue- and white-collar workers over 15 years, whereas the third longitudinal study (South Korea) did not find a difference regarding the incidence of depressive symptoms over 6 years. Results from the cross-sectional studies showed associations between self-employment and poor general mental health and stress, but were inconsistent regarding other mental outcomes. Most studies from South Korea found a higher prevalence of mental disorders among the self-employed compared to employees, whereas the results of cross-sectional studies from outside Asia were less consistent. In conclusion, we found evidence from population-based studies for a link between self-employment and increased risk of mental illness. Further longitudinal studies are needed examining the potential risk for the development of mental disorders in specific subtypes of the self-employed.
The Quality of Acute Stroke Care-an Analysis of Evidence-Based Indicators in 260 000 Patients
(2014)
Background: Stroke patients should be cared for in accordance with evidence-based guidelines. The extent of implementation of guidelines for the acute care of stroke patients in Germany has been unclear to date. Methods: The regional quality assurance projects that cooperate in the framework of the German Stroke Registers Study Group (Arbeitsgemeinschaft Deutscher Schlaganfall-Register, ADSR) collected data on the care of stroke patients in 627 hospitals in 2012. The quality of the acute hospital care of patients with stroke or transient ischemic attack (TIA) was assessed on the basis of 15 standardized, evidence-based quality indicators and compared across the nine participating regional quality assurance projects. Results: Data were obtained on more than 260 000 patients nationwide. Intravenous thrombolysis was performed in 59.7% of eligible ischemic stroke patients patients (range among participating projects, 49.7-63.6%). Dysphagia screening was documented in 86.2% (range, 74.8-93.1%). For the following indicators, the defined targets were not reached for all of Germany: antiaggregation within 48 hours, 93.4% (range, 86.6-96.4%); anticoagulation for atrial fibrillation, 77.6% (range, 72.4-80.1%); standardized dysphagia screening, 86.2% (range, 74.8-93.1%); oral and written information of the patients or their relatives, 86.1% (range, 75.4-91.5%). The rate of patients examined or treated by a speech therapist was in the target range. Conclusion: The defined targets were reached for most of the quality indicators. Some indicators, however, varied widely across regional quality assurance projects. This implies that the standardization of care for stroke patients in Germany has not yet been fully achieved.
Psychosocial factors affect mental health and health-related quality of life (HRQL) in a complex manner, yet gender differences in these interactions remain poorly understood. We investigated whether psychosocial factors such as social support and personal and work-related concerns impact mental health and HRQL differentially in women and men during the first year of the COVID-19 pandemic. Between June and October 2020, the first part of a COVID-19-specific program was conducted within the “Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB)” cohort study, a representative age- and gender-stratified sample of the general population of Würzburg, Germany. Using psychometric networks, we first established the complex relations between personal social support, personal and work-related concerns, and their interactions with anxiety, depression, and HRQL. Second, we tested for gender differences by comparing expected influence, edge weight differences, and stability of the networks. The network comparison revealed a significant difference in the overall network structure. The male (N = 1370) but not the female network (N = 1520) showed a positive link between work-related concern and anxiety. In both networks, anxiety was the most central variable. These findings provide further evidence that the complex interplay of psychosocial factors with mental health and HRQL decisively depends on gender. Our results are relevant for the development of gender-specific interventions to increase resilience in times of pandemic crisis.
Background
Chronic kidney disease (CKD) is a common comorbid condition in coronary heart disease (CHD). CKD predisposes the patient to acute kidney injury (AKI) during hospitalization. Data on awareness of kidney dysfunction among CHD patients and their treating physicians are lacking. In the current cross-sectional analysis of the German EUROASPIRE IV sample we aimed to investigate the physician’s awareness of kidney disease of patients hospitalized for CHD and also the patient’s awareness of CKD in a study visit following hospital discharge.
Methods
All serum creatinine (SCr) values measured during the hospital stay were used to describe impaired kidney function (eGFR\(_{CKD-EPI}\) < 60 ml/min/1.73m2) at admission, discharge and episodes of AKI (KDIGO definition). Information extracted from hospital discharge letters and correct ICD coding for kidney disease was studied as a surrogate of physician’s awareness of kidney disease. All patients were interrogated 0.5 to 3 years after hospital discharge, whether they had ever been told about kidney disease by a physician.
Results
Of the 536 patients, 32% had evidence for acute or chronic kidney disease during the index hospital stay. Either condition was mentioned in the discharge letter in 22%, and 72% were correctly coded according to ICD-10. At the study visit in the outpatient setting 35% had impaired kidney function. Of 158 patients with kidney disease, 54 (34%) were aware of CKD. Determinants of patient’s awareness were severity of CKD (OR\(_{eGFR}\) 0.94; 95%CI 0.92–0.96), obesity (OR 1.97; 1.07–3.64), history of heart failure (OR 1.99; 1.00–3.97), and mentioning of kidney disease in the index event’s hospital discharge letter (OR 5.51; 2.35–12.9).
Conclusions
Although CKD is frequent in CHD, only one third of patients is aware of this condition. Patient’s awareness was associated with kidney disease being mentioned in the hospital discharge letter. Future studies should examine how raising physician’s awareness for kidney dysfunction may improve patient’s awareness of CKD.
Background
Anemia is common and is associated with impaired clinical outcomes in diabetic chronic kidney disease (CKD). It may be explained by reduced erythropoietin (EPO) synthesis, but recent data suggest that EPO-resistance and diminished iron availability due to inflammation contribute significantly. In this cohort study, we evaluated the impact of hepcidin-25—the key hormone of iron-metabolism—on clinical outcomes in diabetic patients with CKD along with endogenous EPO levels.
Methods
249 diabetic patients with CKD of any stage, excluding end-stage renal disease (ESRD), were enrolled (2003–2005), if they were not on EPO-stimulating agent and iron therapy. Hepcidin-25 levels were measured by radioimmunoassay. The association of hepcidin-25 at baseline with clinical variables was investigated using linear regression models. All-cause mortality and a composite endpoint of CKD progression (ESRD or doubling of serum creatinine) were analyzed by Cox proportional hazards models.
Results
Patients (age 67 yrs, 53% male, GFR 51 ml/min, hemoglobin 131 g/L, EPO 13.5 U/L, hepcidin-25 62.0 ng/ml) were followed for a median time of 4.2 yrs. Forty-nine patients died (19.7%) and forty (16.1%) patients reached the composite endpoint. Elevated hepcidin levels were independently associated with higher ferritin-levels, lower EPO-levels and impaired kidney function (all p<0.05). Hepcidin was related to mortality, along with its interaction with EPO, older age, greater proteinuria and elevated CRP (all p<0.05). Hepcidin was also predictive for progression of CKD, aside from baseline GFR, proteinuria, low albumin- and hemoglobin-levels and a history of CVD (all p<0.05).
Conclusions
We found hepcidin-25 to be associated with EPO and impaired kidney function in diabetic CKD. Elevated hepcidin-25 and EPO-levels were independent predictors of mortality, while hepcidin-25 was also predictive for progression of CKD. Both hepcidin-25 and EPO may represent important prognostic factors of clinical outcome and have the potential to further define “high risk” populations in CKD.
Background and purpose
The effects of the coronavirus disease 2019 (COVID-19) pandemic on telemedical care have not been described on a national level. Thus, we investigated the medical stroke treatment situation before, during, and after the first lockdown in Germany.
Methods
In this nationwide, multicenter study, data from 14 telemedical networks including 31 network centers and 155 spoke hospitals covering large parts of Germany were analyzed regarding patients' characteristics, stroke type/severity, and acute stroke treatment. A survey focusing on potential shortcomings of in-hospital and (telemedical) stroke care during the pandemic was conducted.
Results
Between January 2018 and June 2020, 67,033 telemedical consultations and 38,895 telemedical stroke consultations were conducted. A significant decline of telemedical (p < 0.001) and telemedical stroke consultations (p < 0.001) during the lockdown in March/April 2020 and a reciprocal increase after relaxation of COVID-19 measures in May/June 2020 were observed. Compared to 2018–2019, neither stroke patients' age (p = 0.38), gender (p = 0.44), nor severity of ischemic stroke (p = 0.32) differed in March/April 2020. Whereas the proportion of ischemic stroke patients for whom endovascular treatment (14.3% vs. 14.6%; p = 0.85) was recommended remained stable, there was a nonsignificant trend toward a lower proportion of recommendation of intravenous thrombolysis during the lockdown (19.0% vs. 22.1%; p = 0.052). Despite the majority of participating network centers treating patients with COVID-19, there were no relevant shortcomings reported regarding in-hospital stroke treatment or telemedical stroke care.
Conclusions
Telemedical stroke care in Germany was able to provide full service despite the COVID-19 pandemic, but telemedical consultations declined abruptly during the lockdown period and normalized after relaxation of COVID-19 measures in Germany.
Aims
We aimed to analyze prevalence and predictors of NOAC off-label under-dosing in AF patients before and after the index stroke.
Methods
The post hoc analysis included 1080 patients of the investigator-initiated, multicenter prospective Berlin Atrial Fibrillation Registry, designed to analyze medical stroke prevention in AF patients after acute ischemic stroke.
Results
At stroke onset, an off-label daily dose was prescribed in 61 (25.5%) of 239 NOAC patients with known AF and CHA2DS2-VASc score ≥ 1, of which 52 (21.8%) patients were under-dosed. Under-dosing was associated with age ≥ 80 years in patients on rivaroxaban [OR 2.90, 95% CI 1.05-7.9, P = 0.04; n = 29] or apixaban [OR 3.24, 95% CI 1.04-10.1, P = 0.04; n = 22]. At hospital discharge after the index stroke, NOAC off-label dose on admission was continued in 30 (49.2%) of 61 patients. Overall, 79 (13.7%) of 708 patients prescribed a NOAC at hospital discharge received an off-label dose, of whom 75 (10.6%) patients were under-dosed. Rivaroxaban under-dosing at discharge was associated with age ≥ 80 years [OR 3.49, 95% CI 1.24-9.84, P = 0.02; n = 19]; apixaban under-dosing with body weight ≤ 60 kg [OR 0.06, 95% CI 0.01-0.47, P < 0.01; n = 56], CHA2DS2-VASc score [OR per point 1.47, 95% CI 1.08-2.00, P = 0.01], and HAS-BLED score [OR per point 1.91, 95% CI 1.28-2.84, P < 0.01].
Conclusion
At stroke onset, off-label dosing was present in one out of four, and under-dosing in one out of five NOAC patients. Under-dosing of rivaroxaban or apixaban was related to old age. In-hospital treatment after stroke reduced off-label NOAC dosing, but one out of ten NOAC patients was under-dosed at discharge.